News Mylan expects first US Herceptin biosimilar launch Deal with Roche paves way for near-copy of breast cancer blockbuster
News Mylan challenges Amgen's Neulasta in US Mylan and Biocon file biosimilar of white blood cell booster
News Teva's CEO Vigodman steps down Firm searches for new leader, chairman takes over on interim basis.
News Embattled Mylan files Herceptin biosimilar in US But senators call for investigation into EpiPen schools contracts.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
